TABLE 2.
Antibiotic consumption as mean DDD per 1,000 inhabitants per day (DDD/1,000/D) from 2017 to 2019 by antibiotic class.
Rank | Substance | ATC code | Mean DDD/1,000/D ± SD |
---|---|---|---|
J01—antibacterials for systemic use | |||
1 | Doxycycline | J01AA02 | 20.01 ± 24.529 |
2 | Amoxicillin | J01CA04 | 16.759 ± 19.538 |
3 | Trimethoprim-sulfamethoxazole | J01EE01 | 12.422 ± 6.851 |
4 | Erythromycin | J01FA01 | 7.159 ± 2.027 |
5 | Ciprofloxacin | J01MA02 | 4.616 ± 3.058 |
6 | Azithromycin | J01FA10 | 2.711 ± 0.311 |
7 | Norfloxacin and tinidazole | J01RA13 | 2.265 ± 0.31 |
8 | Combinations of penicillins | J01CR50 | 1.33 ± 0.337 |
9 | Procaine benzylpenicillin | J01CE09 | 0.953 ± 1.144 |
10 | Phenoxymethylpenicillin | J01CE02 | 0.808 ± 0.816 |
11 | Levofloxacin | J01MA12 | 0.707 ± 0.466 |
12 | Tetracycline | J01AA07 | 0.655 ± 0.732 |
13 | Amoxicillin and beta-lactamase inhibitor | J01CR02 | 0.452 ± 0.105 |
14 | Benzylpenicillin | J01CE01 | 0.414 ± 0.646 |
15 | Ceftriaxone | J01DD04 | 0.372 ± 0.049 |
16 | Ampicillin | J01CA01 | 0.252 ± 0.345 |
17 | Cefalexin | J01DB01 | 0.241 ± 0.164 |
18 | Chloramphenicol | J01BA01 | 0.194 ± 0.044 |
19 | Cefixime | J01DD08 | 0.101 ± 0.045 |
20 | Ampicillin and beta-lactamase inhibitor | J01CR01 | 0.087 ± 0.123 |
J04—antimycobacterials | |||
1 | Rifampicin and isoniazid | J04AM02 | 1.458 ± 1.657 |
2 | Isoniazid | J04AC01 | 0.752 ± 0.297 |
3 | Ethambutol | J04AK02 | 0.017 ± 0.021 |
4 | Pyrazinamide | J04AK01 | 0.01 ± 0.017 |
5 | Rifampicin | J04AB02 | 0 ± 0 |
6 | Clofazimine | J04BA01 | 0 ± NA |
P01AB—nitroimidazole antiprotozoal agents | |||
1 | Metronidazole (parenteral) | P01AB01 | 5.248 ± 1.723 |
2 | Tinidazole | P01AB02 | 0.387 ± 0.231 |
3 | Secnidazole | P01AB07 | 0.024 ± 0.005 |
4 | Ornidazole | P01AB03 | 0.007 ± 0.013 |
ATC, Anatomical Therapeutic Chemical; DDD, defined daily doses.